MSA-2 |
A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… |
10 mg |
30140-10 |
More Info
|
MSA-2 |
A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… |
5 mg |
30140-5 |
More Info
|
MSAB |
An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… |
10 mg |
36497-10 |
More Info
|
MSAB |
An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… |
100 mg |
36497-100 |
More Info
|
MSAB |
An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… |
25 mg |
36497-25 |
More Info
|
MSAB |
An inhibitor of Wnt/β-catenin signaling; selectively inhibits the pro… |
50 mg |
36497-50 |
More Info
|
MSC2530818 |
A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… |
1 mg |
29669-1 |
More Info
|
MSC2530818 |
A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… |
10 mg |
29669-10 |
More Info
|
MSC2530818 |
A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… |
25 mg |
29669-25 |
More Info
|
MSC2530818 |
A Cdk8 inhibitor (IC50 = 2.6 nM); selective for Cdk8 over a panel of 264 k… |
5 mg |
29669-5 |
More Info
|
MSDC-0160 |
A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… |
1 mg |
71748-1 |
More Info
|
MSDC-0160 |
A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… |
10 mg |
71748-10 |
More Info
|
MSDC-0160 |
A thiazolidinedione; inactivates MPC (IC50 = 1.2 µM) without affecti… |
5 mg |
71748-5 |
More Info
|
MSDC-0602 |
A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… |
10 mg |
27829-10 |
More Info
|
MSDC-0602 |
A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… |
100 mg |
27829-100 |
More Info
|
MSDC-0602 |
A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… |
25 mg |
27829-25 |
More Info
|
MSDC-0602 |
A PPARγ-sparing thiazolidinedione derivative; binds only weakly to P… |
50 mg |
27829-50 |
More Info
|
MS023 (hydrochloride) |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
1 mg |
18361-1 |
More Info
|
MS023 (hydrochloride) |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
10 mg |
18361-10 |
More Info
|
MS023 (hydrochloride) |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
25 mg |
18361-25 |
More Info
|
MS023 (hydrochloride) |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
5 mg |
18361-5 |
More Info
|
MS049 (hydrochloride) |
A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… |
1 mg |
18348-1 |
More Info
|
MS049 (hydrochloride) |
A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… |
10 mg |
18348-10 |
More Info
|
MS049 (hydrochloride) |
A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… |
25 mg |
18348-25 |
More Info
|
MS049 (hydrochloride) |
A selective inhibitor of PRMT4 (IC50 = 34 nM) and PRMT6 (IC50 = 43 nM); re… |
5 mg |
18348-5 |
More Info
|
MS 245 (oxalate) |
An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… |
1 mg |
11936-1 |
More Info
|
MS 245 (oxalate) |
An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… |
10 mg |
11936-10 |
More Info
|
MS 245 (oxalate) |
An antagonist of 5-HT6 (Ki = 2.3 nM for the human recombinant receptor); s… |
5 mg |
11936-5 |
More Info
|
MS-PPOH |
Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… |
1 mg |
75770-1 |
More Info
|
MS-PPOH |
Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… |
10 mg |
75770-10 |
More Info
|
MS-PPOH |
Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… |
5 mg |
75770-5 |
More Info
|
MS-PPOH |
Arachidonic acid is converted by microsomal CYP450 enzymes to a variety of… |
50 mg |
75770-50 |
More Info
|
MST-312 |
A telomerase inhibitor (IC50 = 0.67 µM in a TRAP assay); selective f… |
10 mg |
24301-10 |
More Info
|
MST-312 |
A telomerase inhibitor (IC50 = 0.67 µM in a TRAP assay); selective f… |
5 mg |
24301-5 |
More Info
|
MSX-122 |
A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… |
1 mg |
23426-1 |
More Info
|
MSX-122 |
A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… |
10 mg |
23426-10 |
More Info
|
MSX-122 |
A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… |
25 mg |
23426-25 |
More Info
|
MSX-122 |
A partial antagonist of CXCR4; reduces inflammation in a mouse model of ex… |
5 mg |
23426-5 |
More Info
|
MSX-130 |
An imidazole; displays excitation / emission maxima of 382 / 466 nm, respe… |
10 mg |
36804-10 |
More Info
|
MSX-130 |
An imidazole; displays excitation / emission maxima of 382 / 466 nm, respe… |
25 mg |
36804-25 |
More Info
|
MSX-130 |
An imidazole; displays excitation / emission maxima of 382 / 466 nm, respe… |
5 mg |
36804-5 |
More Info
|
MSX-130 |
An imidazole; displays excitation / emission maxima of 382 / 466 nm, respe… |
50 mg |
36804-50 |
More Info
|
MT-802 |
A PROTAC that drives BTK degradation; induces degradation of BTK in NAMALW… |
25 mg |
36581-25 |
More Info
|
MT-802 |
A PROTAC that drives BTK degradation; induces degradation of BTK in NAMALW… |
5 mg |
36581-5 |
More Info
|
MT-802 |
A PROTAC that drives BTK degradation; induces degradation of BTK in NAMALW… |
50 mg |
36581-50 |
More Info
|
4-MTA |
A methylthio analog of PMA, a hallucinogenic drug that has been scheduled… |
1 mg |
11555-1 |
More Info
|
4-MTA |
A methylthio analog of PMA, a hallucinogenic drug that has been scheduled… |
10 mg |
11555-10 |
More Info
|
4-MTA |
A methylthio analog of PMA, a hallucinogenic drug that has been scheduled… |
5 mg |
11555-5 |
More Info
|
4-MTA (hydrochloride) |
A selective serotonergic agent which increases serotonin release, blocks i… |
1 mg |
11862-1 |
More Info
|
4-MTA (hydrochloride) |
A selective serotonergic agent which increases serotonin release, blocks i… |
10 mg |
11862-10 |
More Info
|